Brookstone Capital Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.04M | Sell |
8,572
-5,119
| -37% | -$1.06M | 0.02% | 490 |
|
|
2026
Q1 | $2.89M | Buy |
13,691
+5,107
| +59% | +$1.1M | 0.03% | 403 |
|
|
2025
Q4 | $1.76M | Sell |
8,584
-240
| -3% | -$45.2K | 0.02% | 480 |
|
|
2025
Q3 | $1.39M | Buy |
8,824
+1,066
| +14% | +$165K | 0.02% | 528 |
|
|
2025
Q2 | $1.3M | Sell |
7,758
-1,438
| -16% | -$213K | 0.02% | 503 |
|
|
2025
Q1 | $1.27M | Buy |
9,196
+71
| +0.8% | +$9.05K | 0.02% | 499 |
|
|
2024
Q4 | $1.08M | Buy |
9,125
+381
| +4% | +$44.5K | 0.02% | 510 |
|
|
2024
Q3 | $966K | Sell |
8,744
-519
| -6% | -$54.3K | 0.01% | 525 |
|
|
2024
Q2 | $889K | Sell |
9,263
-795
| -8% | -$81K | 0.01% | 521 |
|
|
2024
Q1 | $1.13M | Sell |
10,058
-960
| -9% | -$104K | 0.02% | 465 |
|
|
2023
Q4 | $1.11M | Sell |
11,018
-1,025
| -9% | -$102K | 0.02% | 433 |
|
|
2023
Q3 | $1.12M | Buy |
12,043
+724
| +6% | +$65.4K | 0.02% | 413 |
|
|
2023
Q2 | $1.06M | Sell |
11,319
-184
| -2% | -$15.5K | 0.02% | 421 |
|
|
2023
Q1 | $921K | Sell |
11,503
-3,703
| -24% | -$279K | 0.02% | 469 |
|
|
2022
Q4 | $1.2M | Sell |
15,206
-125
| -0.8% | -$9.5K | 0.02% | 397 |
|
|
2022
Q3 | $1.04M | Buy |
15,331
+604
| +4% | +$38.3K | 0.02% | 393 |
|
|
2022
Q2 | $779K | Buy |
14,727
+652
| +5% | +$37.1K | 0.02% | 465 |
|
|
2022
Q1 | $864K | Sell |
14,075
-45
| -0.3% | -$2.41K | 0.02% | 444 |
|
|
2021
Q4 | $766K | Buy |
14,120
+2,164
| +18% | +$106K | 0.01% | 433 |
|
|
2021
Q3 | $571K | Buy |
11,956
+264
| +2% | +$14.3K | 0.01% | 475 |
|
|
2021
Q2 | $668K | Buy |
11,692
+431
| +4% | +$25.2K | 0.01% | 435 |
|
|
2021
Q1 | $684K | Buy |
11,261
+1,092
| +11% | +$60.3K | 0.03% | 305 |
|
|
2020
Q4 | $545K | Buy |
10,169
+4,073
| +67% | +$211K | 0.02% | 316 |
|
|
2020
Q3 | $286K | Buy |
+6,096
| New | +$313K | 0.01% | 346 |
|
|
2018
Q4 | – | Sell |
-86,143
| Closed | -$4.65M | – | 322 |
|
|
2018
Q3 | $4.65M | Sell |
86,143
-8,229
| -9% | -$421K | 0.35% | 81 |
|
|
2018
Q2 | $4.61M | Buy |
94,372
+14,293
| +18% | +$810K | 0.4% | 82 |
|
|
2018
Q1 | $5.02M | Sell |
80,079
-3,600
| -4% | -$247K | 0.46% | 80 |
|
|
2017
Q4 | $5.13M | Buy |
+83,679
| New | +$5.17M | 0.46% | 88 |
|
|
2015
Q4 | – | Sell |
-24
| Closed | -$2K | – | 250 |
|
|
2015
Q3 | $2K | Sell |
24
-80
| -77% | -$6.68K | ﹤0.01% | 1669 |
|
|
2015
Q2 | $9K | Buy |
+104
| New | +$9.18K | ﹤0.01% | 1276 |
|
Other funds holding CAH
Brookstone Capital Management's CAH Position: Q2 2026 in Review
Brookstone Capital Management reduced its Cardinal Health (CAH) stake by 37% in Q2 2026, selling an estimated $1.06M and leaving 8,572 shares worth $2.04M. The position accounts for 0.02% of the portfolio, ranked #490.
Brookstone Capital Management first reported a position in CAH in Q2 2015 and has held it in 30 quarters since. The position peaked at $5.13M in Q4 2017. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Brookstone Capital Management held 8,572 shares of Cardinal Health worth $2.04M as of Q2 2026.
- Brookstone Capital Management sold 5,119 Cardinal Health shares in Q2 2026, an estimated $1.06M.
- Cardinal Health made up 0.02% of Brookstone Capital Management's portfolio in Q2 2026, its #490 holding.
- Brookstone Capital Management first reported a position in Cardinal Health in Q2 2015 and has held it in 30 quarters since.
- Brookstone Capital Management's Cardinal Health position peaked at $5.13M in Q4 2017.
- 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.